About Base Genomics
Base Genomics is a Healthcare company based in Oxford (United Kingdom) founded in 2019 by Chunxiao Song, Oliver Waterhouse, and Yibin Liu, and was acquired by Exact Sciences in October 2020. In-vitro DNA methylation tests for early cancer detection are offered. Base Genomics has raised $11 million across 1 funding round from investors including Exact Sciences and Oxford Science Enterprises. The company has 19 employees. Its chief executive, as recorded, is Oliver Waterhouse. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is EXACT SCIENCES INNOVATION, LTD.
Company details
Base Genomics was founded in 2019 in Oxford, United Kingdom, and operates in the biotechnology sector focused on epigenetics. TET-assisted pyridine borane sequencing (TAPS) technology is provided for DNA methylation analysis via bisulfite sequencing, enabling early cancer detection and personalized medicine from samples. Additional services include non-invasive prenatal testing, single-cell sequencing, and biomarker discovery.
- Headquarters Oxford, United Kingdom
- Employees 19
- Founders Chunxiao Song, Oliver Waterhouse, Yibin Liu
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website basegenomics.com
- Social LinkedIn X Facebook
- Acquired by Exact Sciences (Oct 2020)
- Legal Name Exact Sciences Innovation, Ltd
- Date of Incorporation 17 Jul, 2019
- Jurisdiction LONDON, ENGLAND
- Total Equity Funding$11M (USD)
in 1 rounds
- Latest Funding Round$11M (USD), Seed
Jun 2020
- InvestorsExact Sciences
& 1 more
- Employee Count19
- Acquired byExact Sciences
(Oct 2020)
Funding Insights of Base Genomics
Base Genomics has successfully raised a total of $11M through 1 strategic funding round. The most recent funding activity was a Seed round of $11 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11M
- Total Rounds 1
- Last Round Seed — $11M
- First Round $11M
(Jun 2020)
- Investors Count 1
All 1 funding rounds of Base Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | $11M | Seed | – | Oxford Science Enterprises | – |
2 investors in total: 2 institutional.
Investors in Base Genomics
Base Genomics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Exact Sciences and Oxford Science Enterprises.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment management services for science ventures are provided in Oxford. | oxfordscienceenterprises.com | Oxford, United Kingdom | ||
Non-invasive molecular diagnostic tests for cancer detection are provided. | 1995 | exactsciences.com | Madison, United States |
Investor details for Base Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Base Genomics
3 people are tracked at Base Genomics (3 in leadership); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Chunxiao Song | Co-Founder | Leadership |
Oliver Waterhouse | Co-Founder & CEO | Leadership |
Yibin Liu | Co-Founder | Leadership |
Complete people profiles for Base Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Base Genomics
3 dated milestones of Base Genomics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Base Genomics is founded.
- Funding First funding round of $11.0M.
- Exit Acquired by Exact Sciences.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Base Genomics (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Base Genomics
Base Genomics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Base Genomics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Oliver Waterhouse is the CEO of Base Genomics, as recorded in our data. They have also founded this company.
Base Genomics is a funded company, having raised a total of $11M across 1 funding round to date. The company's 1st funding round was a Seed of $11M, raised on Jun 2020.
Base Genomics has 19 employees.
Base Genomics was founded in 2019 in Oxford, United Kingdom, and operates in the biotechnology sector focused on epigenetics. TET-assisted pyridine borane sequencing (TAPS) technology is provided for DNA methylation analysis via bisulfite sequencing, enabling early cancer detection and personalized medicine from samples. Additional services include non-invasive prenatal testing, single-cell sequencing, and biomarker discovery.
Base Genomics has 2 investors. Key investors include Exact Sciences, and Oxford Science Enterprises.
Base Genomics operates through Exact Sciences Innovation, Ltd.
Yes. Base Genomics was acquired by Exact Sciences in October 2020.